Naoya Kinota, Haruyuki Takaki, Kaoru Kobayashi, Yasukazu Kako, Hiroshi Kodama, Atsushi Ogasawara, Mitsunari Maruyama, Motonori Takahagi, Junichi Taniguchi, Taiki Moriyama, Hiroyuki Yokoyama, Hisashi Komoto, Ryo Kunimoto, Nahomi Yoshimura, Koichiro Yamakado
PURPOSE: To evaluate the feasibility, safety, and efficacy of radiofrequency (RF) ablation using an ablation system (arfa RF ABLATION SYSTEMⓇ ; Japan Lifeline Co. Ltd.) for treating solid tumors in various organs. MATERIAL AND METHODS: Between October 2019 and August 2021, 80 patients (29 women, 51 men; median age, 70.0 yr) underwent 107 RF ablation sessions using the ablation system to treat 151 tumors in the liver ( n = 86), lung ( n = 51), adrenal gland ( n = 4), pleura ( n = 4), bone ( n = 3), lymph node ( n = 2), and kidney ( n = 1)...
November 4, 2022: Interventional radiology